Funda Pepedil Tanrıkulu

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Hüseyin Saffet Beköz, Nuri Karadurmuş, S. Paydaş et al. · Annals of Oncology · 2017 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran et al. · Turkish Journal of Hematology · 2019 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia

Hayri Bostan, Tayfur Toptaş, Funda Pepedil Tanrıkulu et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 11 citations

Medicine, Oncology, Pharmacology +16